Company news
Sernova Biotherapeutics Inc (TSX:SVA) news
Sernova Biotherapeutics Inc news releases on 6ix. Latest, Jul 25, 2019: Sernova Announces Up to $3 Million Private Placement Financing
Press releases — page 4
Sernova Announces Up to $3 Million Private Placement Financing
July 25, 2019
Sernova's Phase I/II US Clinical Trial for Type-1 Diabetes Advances Following Positive Preliminary Safety and Efficacy Data
July 17, 2019
Sernova Corp Presents Positive Preliminary Safety and Efficacy Data in its Phase I/II Clinical Trial for Type-1 Diabetes
July 3, 2019
Sernova's Principal Investigator to Present Interim Data from the Company's Ongoing Phase I/II Cell Pouch Clinical Trial at the 17th World Congress of the International Pancreas and Islet Transplant Association
June 27, 2019
Sernova Corp Announces Appointment of Deborah Brown to its Board of Directors
May 21, 2019
Sernova Announces Collaboration to Advance Therapeutic Cell Pouch Technologies for the Treatment of Hypothyroidism
April 30, 2019
Sernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical Study for Diabetes
April 11, 2019
Sernova Corp Announces First Patient Implanted with Sernova's Cell Pouch(TM) in a Phase I/II US Clinical Trial for the Treatment of Hypoglycemia Unawareness in Subjects with Type 1 Diabetes
February 11, 2019
Sernova Announces the Appointment of Dr. David Lillicrap, M.D. to its Scientific Advisory Board
January 30, 2019
Sernova to Participate on Diabetes Panel and Present at NobleConXV, 15th Annual Investor Conference January 28th - 29th, 2019
January 28, 2019
Sernova Announces Successful Enrollment Approaching 50% of Subjects in its U.S. Phase I of II Cell Pouch Diabetes Clinical Trial
January 17, 2019
Sernova Announces Enrollment of First Patient in U.S. Phase I/II Study of Cell Pouch(tm) for Treatment in Type 1 Diabetes
December 20, 2018
Sernova Highlights Achievements from the HemAcure Consortium in Developing a Novel Cell-Based Therapy for Hemophilia A
November 20, 2018
Sernova Retains FronTier Flex for Canadian Investor Relations and Marketing
November 9, 2018
Sernova Establishes Comprehensive North American Investor Relations and Communications Strategy
November 6, 2018
Sernova-HemAcure Consortium to Present Achievements in Development of a Regenerative Medicine Approach to Treat Hemophilia A
October 23, 2018
Sernova Obtains FDA Notice of Allowance for Use of Proprietary Cell Pouch System with Continuous Glucose Monitoring Systems in Clinical Trials for Type 1 Diabetes - Video Available on Investmentpitch.com
February 23, 2018
IIROC Trade Resumption - Sernova Corp.
December 11, 2017
IIROC Trade Halt - Sernova Corp.
December 8, 2017
Research Reports Initiated on Healthcare Stocks Titan Medical, Sernova, LED Medical Diagnostics, and Neovasc
February 13, 2017
SeeThruEquity Initiates Coverage on Sernova Corp. (TSX: SVA, OTCQB: SEOVF) with a Price Target of CAD $0.76
October 5, 2015